The surgical resection of the primary tumor increases survival in patients with EGFR-mutant advanced non-small cell lung cancer: a tertiary center cohort study

Tumor resection could increase treatment efficacy of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI) in patients with advanced EGFR-mutant non-small cell lung cancer (NSCLC). This study aimed to retrospectively analyze patients with advanced EGFR-mutant NSCLC from a Taiwanes...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying-Yuan, Su, Po-Lan, Huang, Wei-Li, Chang, Chao-Chun, Yen, Yi-Ting, Lin, Chien-Chung, Tseng, Yau-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800377/
https://www.ncbi.nlm.nih.gov/pubmed/36581631
http://dx.doi.org/10.1038/s41598-022-22957-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800377/
https://www.ncbi.nlm.nih.gov/pubmed/36581631
http://dx.doi.org/10.1038/s41598-022-22957-9

Ejemplares similares